Trends of incidence rate and age at diagnosis for cervical cancer in China, from 2000 to 2014
- PMID: 29353970
- PMCID: PMC5758729
- DOI: 10.21147/j.issn.1000-9604.2017.06.02
Trends of incidence rate and age at diagnosis for cervical cancer in China, from 2000 to 2014
Abstract
Objective: To analyze the trends of incidence rate and age at diagnosis for cervical cancer incidence in China using population-based cancer registration data from 2000 to 2014.
Methods: Data were from National Central Cancer Registry of China. Crude incidence rates (CIRs), age-specific incidence rate, age-standardized incidence rates (ASIRs), age percentage distribution, standardized age percentage distribution, mean age at diagnosis and standardized mean age at diagnosis for cervical cancer in all areas of China, urban China and rural China were calculated separately. The world Segi's population was applied to remove the age structure influence. Joinpoint regression was performed to obtain average annual percent change (AAPC) and age-period-cohort analysis was used to examine the incidence trends.
Results: CIRs and ASIRs for cervical cancer increased in China from 2000 to 2014. The AAPC of ASIRs in China was at 9.2% [95% confidence interval (95% CI): 7.0%-11.5%, P<0.05], and the AAPC in rural areas was relatively high. The age-specific incidence rate in groups aged 0-69 years have significantly increased over time. Groups aged 40-69 years showed the highest incidence risk, and the annual percent changes (APCs) of incidence rate in groups aged 40-59 years in urban China and groups aged 0-49 years in rural China were more than 10%. For each age group, the urban-to-rural incidence rate ratios (IRRs) got close to 1 over time. There were clear birth cohort effects in successive generations born from 1940 to 1970 in China. In rural China, the standardized mean age at diagnosis had significantly declined by 5.18 years. In China, the main peak and secondary peak of standardized age percentages appeared in the groups aged 45-49 and 40-44 years, respectively. In rural China, the main peak of standardized age percentage moved from the group aged 55-59 years to the group aged 45-49 years, and the standardized age percentages of groups aged 25-34 years also increased. In China, the standardized age percentages has significantly increased in groups aged 35-64 and 30-64 years over time, and accounted for about 80% and 85% in 2014, respectively.
Conclusions: The cervical cancer incidence increased in China and the gap of incidence between urban and rural China was narrowed. The trends of increasing cervical cancer incidence among younger women existed in China, especially in rural China. A more appropriate screening, vaccination and health education strategies should be established.
Keywords: Cervical cancer; age; incidence.
Figures





Similar articles
-
[Analysis on mortality of cervical cancer and its temporal trend in women in China, 2006-2012].Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Jan 10;38(1):58-64. doi: 10.3760/cma.j.issn.0254-6450.2017.01.011. Zhonghua Liu Xing Bing Xue Za Zhi. 2017. PMID: 28100378 Chinese.
-
[Trend analysis of cervical cancer incidence and mortality rates in Chinese women during 1989-2008].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2014 Apr;36(2):119-25. doi: 10.3881/j.issn.1000-503X.2014.02.001. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2014. PMID: 24791788 Chinese.
-
Incidence and mortality of cervical cancer in China in 2015.J Natl Cancer Cent. 2022 Feb 3;2(2):70-77. doi: 10.1016/j.jncc.2022.01.002. eCollection 2022 Jun. J Natl Cancer Cent. 2022. PMID: 39034952 Free PMC article.
-
[Trend analysis on incidence and age at diagnosis for lung cancer in cancer registration areas of China, 2000-2014].Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Jun 6;52(6):579-585. doi: 10.3760/cma.j.issn.0253-9624.2018.06.005. Zhonghua Yu Fang Yi Xue Za Zhi. 2018. PMID: 29886678 Chinese.
-
[Analysis on incidence trend of liver cancer in China, 2005-2016].Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Mar 10;43(3):330-335. doi: 10.3760/cma.j.cn112338-20210924-00749. Zhonghua Liu Xing Bing Xue Za Zhi. 2022. PMID: 35345286 Chinese.
Cited by
-
Knowledge and Attitudes Regarding HPV and Vaccination Among Chinese Women Aged 20 to 35 Years in Fujian Province: A Cross-Sectional Study.Cancer Control. 2018 Jan-Mar;25(1):1073274818775356. doi: 10.1177/1073274818775356. Cancer Control. 2018. PMID: 29761723 Free PMC article.
-
Translation and validation of the Chinese version of the MD Anderson symptom inventory for measuring perioperative symptom burden in patients with gynecologic cancer.BMC Womens Health. 2021 Jul 29;21(1):276. doi: 10.1186/s12905-021-01415-0. BMC Womens Health. 2021. PMID: 34325677 Free PMC article.
-
Knowledge and Attitudes towards Human Papillomavirus Vaccination (HPV) among Healthcare Providers Involved in the Governmental Free HPV Vaccination Program in Shenzhen, Southern China.Vaccines (Basel). 2023 May 18;11(5):997. doi: 10.3390/vaccines11050997. Vaccines (Basel). 2023. PMID: 37243101 Free PMC article.
-
Trends in Incidence Rates, Mortality Rates, and Age-Period-Cohort Effects of Cervical Cancer - China, 2003-2017.China CDC Wkly. 2022 Dec 2;4(48):1070-1076. doi: 10.46234/ccdcw2022.216. China CDC Wkly. 2022. PMID: 36751372 Free PMC article.
-
Disparities in the increases of cervical cancer incidence rates: observations from a city-wide population-based study.BMC Cancer. 2022 Apr 15;22(1):419. doi: 10.1186/s12885-022-09531-2. BMC Cancer. 2022. PMID: 35428279 Free PMC article.
References
-
- Chen W, Zheng R, Zuo T, et al. National cancer incidence and mortality in China, 2012. Chin J Cancer Res. 2016;28:1–11. doi: 10.3978/j.issn.1000-9604.2016.02.08. [Chen W, Zheng R, Zuo T, et al. National cancer incidence and mortality in China, 2012. Chin J Cancer Res 2016;28:1-11. <DOI: 10.3978/j.issn.1000-9604.2016.02.08> <PMID: 27041922>] - DOI - PMC - PubMed
-
- Cai Y, Xue M, Chen W, et al. Expenditure of hospital care on cancer in China, from 2011 to 2015. Chin J Cancer Res. 2017;29:253–62. doi: 10.21147/j.issn.1000-9604.2017.03.11. [Cai Y, Xue M, Chen W, et al. Expenditure of hospital care on cancer in China, from 2011 to 2015. Chin J Cancer Res 2017;29:253-62. <DOI: 10.21147/j.issn.1000-9604.2017.03.11> <PMID: 28729776>] - DOI - PMC - PubMed
-
- Chen W, Zheng R, Zhang S, et al. Cancer incidence and mortality in China, 2013. Cancer Lett. 2017;401:63–71. doi: 10.1016/j.canlet.2017.04.024. [Chen W, Zheng R, Zhang S, et al. Cancer incidence and mortality in China, 2013. Cancer Lett 2017;401:63-71. <DOI: 10.1016/j.canlet.2017.04.024> <PMID: 28476483>] - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous